ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001364.1|Cinnamycin_1 # 3 # 1130 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.634	BGC0001364.1|Cinnamycin_1 	3	1130	+	Loose	500	29.6462	OXA-60	36.51	3001808	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GGGTCCGCGGTCACTCCGGAGGCCCTTGAGTCCAAGGCGCTCGACCTTGCTCAGAAGACCGTCTACCTGTGCGGCGATGTATCGGAGATCAGTGCCCGGCGACTGCATGGGGCGGCCCGGGTGTTCATCATCCGGGAACTGTCGGACGGCTATCGTGCAGACGTCGATGGGACATGGCCTGTTGTGGATGTTGGACGTGTTCCCGTCCGTGTCCACGGCGCCGGGGTTTACTACCGCCGCTTCTTCGACCTCGGTGCCGATCACTTCGGGAGCATCCGCGCGGAGCATGCGTTCCAGTCGCTGACGGAATCGACCAAGCCCGGAGCGGCCCATCGCAGTGGGATCTATCTGACGCCCGTCGCGCGTGACGGTGACGAACTGCATTTCCGCCTGCTCCGGTGCTCAACGAACCTTTCGGGGCCGACCGAAGGCTTTCGGCCGACGGACACGGGCATCGTCGATGCTTTGAACCGCGAGGCCGCCTTTGTCTTCCGCGACCATGCCCCGCTGAACCATGTCCTTGCGCAGATCTACCACAACACCCCTGCCACGACCGGGCGCAAGCAGGCCAAGGCCAAGATCTCGGCCCACGCCGACAAGACCAAGGACATGCCGGTCAACGGGATCATGGCCTTCTGCACCTTCTATGACCGGCTCGACAAACTGCAGCCCCTCGCCGATGACGCCTTCGACTACGGTGTGAAAGGCGTCAGCGGCCTGACCAAGCTCCGGTTCCGTCTCAAGGACCCGACCGCAGAACGCGACGCGGTCGCGCTACCGCCGCAGTTCACGCTGACCCTTTATCCCGGCTCCGTGTTCTTCATGCCGCTGTCCACCAACCGCTTGTATACGCACGAGATCCGATCCTCGATGTTGGATGCCGAACTGCTCCCGACCCGTTTGGGGTACGTGGTGCGCTGTTCGAGTGCCGAGGCCGTTCACAAGCACGGCGACACGTTCCTCAAAGTGGACGGCGACCTGGTGAAGCTGGGGCCGCCCACGCCGGAGGGCATGGACAGGCTGCGCAGGCTGTACGCCGAGGAGAACAAGACCACGTCGTTCATTGATTACGGCGACGAGTTGCTTTTCAGCATGAACGAGGGGGACTACGTTGCCCCGAGGCCCTGA	GSAVTPEALESKALDLAQKTVYLCGDVSEISARRLHGAARVFIIRELSDGYRADVDGTWPVVDVGRVPVRVHGAGVYYRRFFDLGADHFGSIRAEHAFQSLTESTKPGAAHRSGIYLTPVARDGDELHFRLLRCSTNLSGPTEGFRPTDTGIVDALNREAAFVFRDHAPLNHVLAQIYHNTPATTGRKQAKAKISAHADKTKDMPVNGIMAFCTFYDRLDKLQPLADDAFDYGVKGVSGLTKLRFRLKDPTAERDAVALPPQFTLTLYPGSVFFMPLSTNRLYTHEIRSSMLDAELLPTRLGYVVRCSSAEAVHKHGDTFLKVDGDLVKLGPPTPEGMDRLRRLYAEENKTTSFIDYGDELLFSMNEGDYVAPRP	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	138.38	gnl|BL_ORD_ID|38|hsp_num:0	47			126	294	cloxacillin; oxacillin; cefalotin
BGC0001364.1|Cinnamycin_2 # 1114 # 1884 # 1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.632	BGC0001364.1|Cinnamycin_2 	1114	1884	+	Loose	500	25.0238	L1 beta-lactamase	32.0	3000582	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	L1 family beta-lactamase	TTGCCCCGAGGCCCTGAGATCTCGGACGAGATCCTTGCGTGCGTCCTGCCGACCGACGAAAACCTCTTCGCAGAGCTGTTTACATCCACTCGATGGGAGGACGTGGGAAAAGGCCGGCAGGGTGCCGTGCTCGCCAGGGTCGATGACGCGGGCGGCGTGCCGCTCGTGCGCACCGCCACGCGTTACGTCAGACCGGCGCAGCGTTTCCGCGCGGTACACGAACGGCTGGCGAACCAGATCCAAGAACATGCAGCGTTTCCGACCGCCTTCAACAACGCCCTGGTCGAGTGCTACACGAACGCTTACAGGAAGATGGGCGGCCACTCCGACCAGGCCCTCGATCTGGCCGACGGGTCGTTCATCGCCGTCTTCTCCTGCTACCGGCACCCTGACGCGGACCCGCCGCGAAAGCTGATCTTCGAGCCGAAAGAACCCGGCGGCGAGAAGTTCGATATTCCCCTCGCCCACAACAGCGTCGTCGCTTTCTCGATTGACTCGAACCGGCGGCTCAAGCACAAGATCGTGCTGGACGCACCCGTCCAGACGCCGGACAACCAATGGTTGGGCGTGACCTTCCGGGCGTCGAAAACGCTGGTTCAGTTCCACGACGGAAACGCTTACCTTCCGCAGGGTGCGCGCCTCACGTTGGCCGACGACGAGCAAAAGGGCGAGTTCTACCAACTCCGGCGCCGCGAGAACAACGAAACAGATTTCGTCTACCCCCCGCTGGCCTACACCATCAGCGAAAGCGACCTGATCCCGCCCGTCTGA	MPRGPEISDEILACVLPTDENLFAELFTSTRWEDVGKGRQGAVLARVDDAGGVPLVRTATRYVRPAQRFRAVHERLANQIQEHAAFPTAFNNALVECYTNAYRKMGGHSDQALDLADGSFIAVFSCYRHPDADPPRKLIFEPKEPGGEKFDIPLAHNSVVAFSIDSNRRLKHKIVLDAPVQTPDNQWLGVTFRASKTLVQFHDGNAYLPQGARLTLADDEQKGEFYQLRRRENNETDFVYPPLAYTISESDLIPPV	MRSTLLAFALSSLALAATLFTFDGAAADASLPQLQAYTVDPSWLQTMAPLQIADHTWQIGTHDLTALLVQTADGLVLIDGGMPQMASYLLTNMKARGTNTGPLRMVLLSHAHTDHAGPVAEIKRRTGAQVVVNAETAVLLARGGSDDLHFGDEITFPPVNADRIVMDREVVKLGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDLLLTPHPGASNWNYAAGSNASEKVLSCKAYADAAEKKFDAQLAKETAGAR	86.78	gnl|BL_ORD_ID|1480|hsp_num:0	1619			141	291	
BGC0001364.1|Cinnamycin_6 # 3433 # 4266 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.788	BGC0001364.1|Cinnamycin_6 	3433	4266	-	Loose	400	26.1794	QnrB78	38.71	3003190	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGACGATCCTGATCACCGGGGCGCGCGGCACGGTCGCGCGCTCCCTCGTACGGCAGCTTCACGACGCGGGCCACCGGGTCCGGGCGGGGGGCCGCGTCCCCGCCGAGGTGGACGCCCCCGCCGGGGTGGAGGTCGTCGCGGCGGACCCGACGCGTCCGGGCGACCTCGGGCCGGCGCTGGCGGGCGTCGAGAAGGTCTTCGTGTACGCCGAGCGGTCGGGGCTCGGCGGGTTCCTCGCGGCGGCCGGGGCGGCGGGGGTGCGGCACGTGGTGCTGCTGTCCGCCCTCGGCGCGTCCCCGCACGCCGCCGACGCGATCACGCGCGCGCACGGCGAGGCGGAGCGGGCGGTGCTGGACTCGGGCCTGGAGTGGTCGTTCGTGCGGCCCGGCGGCTTCGCGACGAACCGGCTGATGTGGGCGCCGATGACGAGGGCGGGCGGGCCGGTGCTGGACCCGTTCCCCGAGTCGCAGTCGGCGCTGGTCCACGAGGCGGACGTCGCGGCGGTCGCGCTGGCGGCCCTCACCCTGCCGGGCCAGGCGGGCGCGATCCACAGCGTGACCGGGCCGGAGTCGCAGACGGCGCGGCGGCACGCCGAGCTGATCGGCGAGGCGATCGGCCGCCCGGTCGAGGTCGCGGCGCAGAGCCTGGACGACTACCAGGCGTCGCTGGCGGACCGGCTCCCGCCGGACCTGCTGGAGGCCCGCATCGCGCGCCTCGCGGCGCTCGTCGGCCGCGCGCAGCCGACGACCGACACCGTCCGCACCGTGACGGGCCGCCCCGCGCGGACGTTCGCGCGGTGGGCGGCCGACCACGCGGCCGACTTCACCGGCTGA	MTILITGARGTVARSLVRQLHDAGHRVRAGGRVPAEVDAPAGVEVVAADPTRPGDLGPALAGVEKVFVYAERSGLGGFLAAAGAAGVRHVVLLSALGASPHAADAITRAHGEAERAVLDSGLEWSFVRPGGFATNRLMWAPMTRAGGPVLDPFPESQSALVHEADVAAVALAALTLPGQAGAIHSVTGPESQTARRHAELIGEAIGRPVEVAAQSLDDYQASLADRLPPDLLEARIARLAALVGRAQPTTDTVRTVTGRPARTFARWAADHAADFTG	MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG	129.44	gnl|BL_ORD_ID|4920|hsp_num:0	5911			516	609	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0001364.1|Cinnamycin_9 # 5517 # 6530 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.708	BGC0001364.1|Cinnamycin_9 	5517	6530	-	Loose	600	26.1794	SME-3	41.03	3002381	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SME beta-lactamase	ATGCGGTCCCTACGAACACTCATCGGCGTGACGGCGGCGGCCGCGTTGGTCGCCACGGGAACGGCGACGGCGGCCGGCGCCGCGCCCGCCGCCCCGGCCGCGAAGACGACGGCGGCGACCACCGCCGCCACCCCCAGGCTCACCGGCGGCGCGGCCGTGAACAGCGCGTCCGCCGCCGCGAAGGTCGCCAAGTACTGGACGGCCGCGCGGATGAAGGCCGCCAAGCCGGTGCCCGAGCCGCGCTCCGCGCGCGGGACGCTGTCGGCCAAGGCCGCGCCGACCGGGCCCGCGGGGTCCACGCCGTCCGCCAGGGCCGTCGCGTCGGCGGCGAACAAGCTCGCCGGCGGGAACGCCAAGCTCGCGGCGTCCATCACCGAGTCGGCGGTGGTCGGAAAGGTGTTCTTCCACAAGCCGAGCGGCGGCGACTGGGTGTGCTCGGCGAGCGCGCTCAACAGCGCGTCCAAGCAGCTCGTCATCACCGCGGGCCACTGCGTCCACGAGGGCGCGGGCGGGAACTGGGTGACGAACTGGACGTTCGCCCCGCGTTACCGCAGCGGTTCCCGGCCGTTCGGCACGTTCGCGGCCAAGCAGTTCCGGACGTTCAATTCGTGGATCAGCAGCAGCGACCAGGACCGCGACGTCGCAATGGTGACGACCTGGCCGCTGAATGGCAACAAGGTCGTGAACGTGGTGGGCGGGAACGGCCTCAACTGGAACTGGGGCAAGACCGTCGCGGTGACCATTCTCGGTTACCCGCAGAATGCCAACGGCGGTGAGATCCAGCAGTGGTGCCAGGGCACGACGTACGACGGCGGCGGCAACAAGATCGCCCTCGGCTGCAACTTCAACGGCGGGTCCAGCGGCGGCCCGTGGATCATGAACTTCGACAACAACACGGGCCTCGGCCAGACCGACGGCGTCATGAGCACGATCGACGGGAACGGCGTGAACCGGGCGTCGTACTTCGACGACGCGGTCAAGGCGATGTTCGACGCGCAGGGCAGCGTCACCTGA	MRSLRTLIGVTAAAALVATGTATAAGAAPAAPAAKTTAATTAATPRLTGGAAVNSASAAAKVAKYWTAARMKAAKPVPEPRSARGTLSAKAAPTGPAGSTPSARAVASAANKLAGGNAKLAASITESAVVGKVFFHKPSGGDWVCSASALNSASKQLVITAGHCVHEGAGGNWVTNWTFAPRYRSGSRPFGTFAAKQFRTFNSWISSSDQDRDVAMVTTWPLNGNKVVNVVGGNGLNWNWGKTVAVTILGYPQNANGGEIQQWCQGTTYDGGGNKIALGCNFNGGSSGGPWIMNFDNNTGLGQTDGVMSTIDGNGVNRASYFDDAVKAMFDAQGSVT	MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNTFGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYYSPITTKYKGSGMTLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGDKRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTGSCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID	114.63	gnl|BL_ORD_ID|1391|hsp_num:0	1512			486	603	
BGC0001364.1|Cinnamycin_10 # 6867 # 7916 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.746	BGC0001364.1|Cinnamycin_10 	6867	7916	-	Loose	750	31.187	tet(X6)	40.0	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGAAGGCGATCAGCGTTGTTCCGGGCGATCCGGACTCGGTGGAGGTGCGGGACGTCGCGGAGCCGCGGCCCGGCGCGGACGAGCTGCTGGTCCGGGGCCGCCTGCTCGGCATCTGCGGAACGGACGCCGACATCGTCTCCGGTCCGGGCTACGGCTGGGCCCCGCCGGGCTCGGACCGGCTCGTCATCGGGCACGAGTCGCTGGGCACCGTCCTGCACGCGCCGGACGGCAGCGGGTTCGCGCCGGGCGACCTGGTCGCGGGCGCGGTGCGGCGGCCCGACCCCGAGCCGTGCGTGCCGTGCGCGCACGGCGAGTGGGACTTCTGCAGCAACGGCCGGTACACCGAGCGCGGCATCAAGGAGCTGGACGGGTACGGCGCGCAGTGCTGGACGGTCGAGACCGACTTCGCGGTCAGGCTGGACCCGGCGCTGGGCGACTGCGGCGTCCTGCTGGAGCCGACCTCGGTGGTCGCGAAGGCGTGGGCGCAGGCCGACCGGTTCACCGGCCGCACGTCGGCGCGGCCCCGGACGGCGCTGGTCACGGGCGCGGGCCCGATCGGGCTGCTGGCCGCGCTGCTCGGCGTGCAGCGGGGGCTGGACGTCACCGTCCTGGACGTCAACGACCGGGGCCCGAAGGCCGAGCTGGTCACCGACCTCGGCGCGCGGTTCCACGTCGGGAGCGTCGCGGACCTCGGCCTCTGCCCGGACGTGGTGATCGAATGCACGGGCCACGGCCCGCTGGTCGCGGAGCTGGCGGCGGCGTCGGCGCCGAACGCGGTGATCTGCCTGGCGGGGATCTCGTCGCGGCCGGGTTCGGCCACGGTGGACCTCGACGAGGTCAACAAGGAGATCGTCCTGCGGAACACGCTGCTGTTCGGATCGGTGAGCGCGTCGCCGGGCGACTTCCGGCGGGCCGCCGACGCGCTCGCCCGCGCCGACCGCGACTGGCTGTCGCGGCTCATCACGCGGCGCGTCCCGATGGAGGAGTTCGCGCGCAACGTTCGGAAGGACCCCGACGACGTGAAGGTCGTCGTGGATCTGGAGGCGTGA	MKAISVVPGDPDSVEVRDVAEPRPGADELLVRGRLLGICGTDADIVSGPGYGWAPPGSDRLVIGHESLGTVLHAPDGSGFAPGDLVAGAVRRPDPEPCVPCAHGEWDFCSNGRYTERGIKELDGYGAQCWTVETDFAVRLDPALGDCGVLLEPTSVVAKAWAQADRFTGRTSARPRTALVTGAGPIGLLAALLGVQRGLDVTVLDVNDRGPKAELVTDLGARFHVGSVADLGLCPDVVIECTGHGPLVAELAAASAPNAVICLAGISSRPGSATVDLDEVNKEIVLRNTLLFGSVSASPGDFRRAADALARADRDWLSRLITRRVPMEEFARNVRKDPDDVKVVVDLEA	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	92.33	gnl|BL_ORD_ID|4802|hsp_num:0	3797			3	108	tetracycline; minocycline; oxytetracycline
BGC0001364.1|Cinnamycin_11 # 8004 # 10004 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.763	BGC0001364.1|Cinnamycin_11 	8004	10004	-	Loose	650	196.052	tetA(58)	39.62	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACGCTGCCCGCGGACGCTCCTCCGGCGGCCGCCGCGGCGGCGGTCCCGGCGATCCGGGCGGCGGGGCTGCGCAAGCGGTATCCGGGCGTCACGGCGGTGGACGGGGTGGACCTGTGCGTCGCGCCGGGCGAGAGCTTCGGGTTCCTCGGGCCGAACGGGGCGGGCAAGTCCACGACGATCGCGATGCTGACGACGCTGGCCGTGCCCACGGCGGGTCGGGTGGAGATCGCGGGCCACGACACCCGGACCGACCCGGTCGCGGCGCGCCGCAGCATCGGGCTGATCTTCCAGGAGTCGACGCTCGACGGGGAGCTGACCGCCGCCGAGAACCTGCGGTTCCACGCCGACCTGTACGACGTGCCCGTCGAGCGGGTTCCCGCGCGGGTCGCCGAGACGCTGGCGCTCGTCGGGCTGACGGACTGCCGGGACCGGCTCGTCCGGACGCTGTCGGGCGGGATGCGGCGGCGGCTGGAGATCGCGCGGGCGCTGCTGCACCGGCCGCGCGTGCTGTTCATGGACGAGCCGACGATCGGGCTGGACCCGCGCACCCGCGCGGACGTCTGGCGGTACCTGCGGCTGGTCCGCGAGCGCGAGGCCGTCACGCTGTTCCTCACCACGCACTATCTGGACGAGGCCGAGCAGTGCGACCGCGTCGCGATCCTGCACGGCGGCCGCATCGTCGCGCAGGGCAGCCCGGCGGAGCTGAAGTCGGTGCTCGGCGCGGACCGGGTGGAGCTGCGCACCGGCGACGACGCGGCGGCGGCGCGGGTGCTGCGCGAGCGGTTCGGCGCGGCCGTCGCCGAGGGGCCGGGCGGGCTGGCGTTCCGCGCGCCCGACAGCGCGCGGGTGCTGCCGCGCCTGTTCGCGGAGCTGGACGTGCCGGTGTTCGAGGCGCGGGTGACGCCGCCGTCGCTGGACGACGTGTTCCTGCACCACACGGGCCACCGCATCCGCGACGACACCGAGGACGCACCCGCCCCGCCACCGGACACGGGCACGGGCGTCGGCGCGGGCACTGACCTGAGCGCGGGCACCGCCTCACGCGCGGGCGCGGGCGCCGACTCGGGCCCAAGCGCGAACACGGGCACGGGCGCGGACGCTGGCACGGGCGTGCGCACGGGCGCGGACCCGCGCACGGACCCGCGTGCGGGCCTGGGCGCGGACCCGCGTGCGGGTGGTTGCGCGGGGCGGGGCGGGGTTCGGGCGGAGTTGCGGGCGATGCGGATGGTGTGGCGGCGGGAGATGCTGCACTTCGGGCGCGACCGCGCCGGGACGGCGATCTCGCTGCTCCAGCCGCTGCTGTTCCTGTTCATCCTCGGCGTCGGCCTCGCGGGGCTGATGTCGGGCGTCAGCAGCCGCTCGTACCAGCTCTTCCTGTTCTCGGGGGCGCTGGTGACGGCGGCGCAGGGCCCGGCGATCGGCGCGGGCTCGTCGATCCTGTGGGACCGGCAGGCCGGGTTCCTGCGGGAGATGCTGGCCGGTCCCGTCCACCGGGGCACGCTGCTGCTCGGCAAGTGCCTGGGCGGCGCGACGGTCGCGACGTGCCAGGCGGGGGTCCTGCTGGCGGCCGGGTGGCTGATCGGCGTCCCGCACGACGCGGTGCTGACGGTGCTGCTGCTCGGCCAGCTCGCGCTCGCGGCGCTGGCGATGACGGCGCTGTCGATCCTGCTGGCGACGTTCATCCGCCGTCCGCAGACGTTCGGGACGGCGGTGACCGTCCTGGCCGCACCGCTGGTGTTCCTGTCGGGCTCGATGTTCCCGCTCACGGCGATGCCGGGCTGGATGGCGCGCGTCGCGCTGGCGAACCCGCTGACGTACGCGGTGGACGCGATGCGCCGGACGATGGCGGCGCGGCTGCCGGCGACGCCGGCGCCGCTGTTCCACCCGCTGACGTGGGGTTCGTGGCATCCGTCCGTCGTCCTGGAGTGGGCGCTGGTGACGGGTCTGGCGCTGCTCGCGCTGGGGTGGGCGGCGCGCCGCTTCTCCCGCGCCGAGTGA	MTLPADAPPAAAAAAVPAIRAAGLRKRYPGVTAVDGVDLCVAPGESFGFLGPNGAGKSTTIAMLTTLAVPTAGRVEIAGHDTRTDPVAARRSIGLIFQESTLDGELTAAENLRFHADLYDVPVERVPARVAETLALVGLTDCRDRLVRTLSGGMRRRLEIARALLHRPRVLFMDEPTIGLDPRTRADVWRYLRLVREREAVTLFLTTHYLDEAEQCDRVAILHGGRIVAQGSPAELKSVLGADRVELRTGDDAAAARVLRERFGAAVAEGPGGLAFRAPDSARVLPRLFAELDVPVFEARVTPPSLDDVFLHHTGHRIRDDTEDAPAPPPDTGTGVGAGTDLSAGTASRAGAGADSGPSANTGTGADAGTGVRTGADPRTDPRAGLGADPRAGGCAGRGGVRAELRAMRMVWRREMLHFGRDRAGTAISLLQPLLFLFILGVGLAGLMSGVSSRSYQLFLFSGALVTAAQGPAIGAGSSILWDRQAGFLREMLAGPVHRGTLLLGKCLGGATVATCQAGVLLAAGWLIGVPHDAVLTVLLLGQLALAALAMTALSILLATFIRRPQTFGTAVTVLAAPLVFLSGSMFPLTAMPGWMARVALANPLTYAVDAMRRTMAARLPATPAPLFHPLTWGSWHPSVVLEWALVTGLALLALGWAARRFSRAE	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	194.17	gnl|BL_ORD_ID|2243|hsp_num:0	2517			48	981	tetracycline
BGC0001364.1|Cinnamycin_13 # 10926 # 14147 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.759	BGC0001364.1|Cinnamycin_13 	10926	14147	-	Loose	1190	28.4906	novA	31.17	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAACCAGCTCTACCCCGCGGACATCGCGGCCCGCGCCGCGAACCTGTCCGAGCGGGCGCGGATCGTCGCCGCGCTCGCCCCGCCCCCGGACGCCCCGCACCCCGGCGCCGGGCCGCTCGACCCGTTCGACGCCTGGAAGACCCGGCGGGTCGCCGACCGCCTCGCCGCGCGGTTCCGCGAGGAGGCGCGGCGCGGCGCCGCCCCCGCCCGGCACACCGAGGCCGCGCTGACCGAGACGCTGACCGCCTACCGGCGGCACGAACTGGGCCTGGCCGACCCGGCCGACCCGTTCGGCCGCGCCGTGCGCGACGCGCAGCGCGCGTGGCTGCCCGTCTACACCGCCGCGCTGGACGGGTTCCGGCCCGAGTCGGAGGAGGCGGCGCGCGCGGGCTGGCGGGAGCCGGAGGTGTACTATGGGCGGCTCGCCAAGGCGTGCGAGCCGTTCCTGCTCGAACTCGGCCGCCGTCTGACGGCCGTCCTGGACGCCGCGCCCGGCGCGGGGCCGGTCGTCGACCGCCGCCTCGTCGAGGAGTTCCAGCTCCGCCTGCTCGACCGGTTCGCGCTGGCGCTGGCGTGGGCGGTCGAGGCCGACACGAAGGTGTACTGCCGGCTGCGCGGCATCGACCCGGCGACCGCGACGACCGACGACTACCTGGCCTTCCTGGACAAGACGTTCGCCGACGCCGAGTCCTACCACCGCTTCTACCTGGACTTCCCCGTCCTCGGCCGCTGGCTGGCGCACACCACCGGGCTGCTCGCCGAGCACGGCCGCGACCTGGTCGTCCGGCTGCGCCGCGACGCCGCCGACGTCGGCGCGGCGTTCTTCGGGCAGCCCGTCGCGGCGGTGCGCTCGGCGGGGCTCGGCCGCTCCGACGACCACGCGGGCGCGCGCGGCGTGGTGATGGTCGGCGCGGAGCTGGCCGACGGGACCGAGGCGACGTTCGTCTACAAGCCGCGCTGCGTGCGCGGCGAGGCCGGGCTGCAGCGGCTGCTGGTCCGGCTGCGCGCCGACGGCGTGCTGGACTTCGCCGACCGGGCCGTCCTCCCCCGCGACGGGTACGGCTACGAGGCGCTGATCCCGGCGGGCCGCAACCGGGTCGCGACGCGGGAGGCGGCCCGGCCGGTGTACGCGGAGCTGGGCGGCTACCTGGCGATCTTCTACGTGCTCGGCGGCGGGGACCTGCACTTCGAGAACGTCCTGGTCGCGGACGGGCACGCGTTCGTCTGCGACTGCGAGACCGTCCTCGGCGCGCTGCCCAAGGGGCAGCCGCGCCCGGCCGGGACGCTGATGGACTCGGTGTTCAAGACCGGCCTGATCGAGTGGCCGACCCCGCCGGACGCGGCCGGGGAGATGCGGCTCAGCGGCTACTCCGGCGGCGGCTCGTTCGAGCTGCCGATGCCGGTGCCGCAGCTCGGGGACCGGCGGATGTCGTTCGAGGCGTCGGTCACGCACCGGGCGGGGCTGCGCGTCGACCCGGGCTCGGCGAACCGGGTGTTCGTCGGGGACGGGCTGGCCGCGCCGGAGGAGTACGTCGCGGACGTCAAGGACGGCTTCGACCGGGTGTACCGCTGGTTCCAGGACGATCCGGACGGCACGGCGGCGCAGGTCGCGGAGCTGTTCTCCGGCACGCGCGTCCGGTTCGTCAACTGGAGCACGCAGATCTACACGCAGCTCCTGCTGGCCGCGCGGCACCCCAAGTGCCTGATGGACCCGCTGGAGGTGGACCTGCTGTTCAACACCGTCCGGACGTTCCCCCGCAACTGGGACGTCGAGGGCGTCCTTCCGGCGTGGGAACTGGAGTCGATGTGGCGGCTGGACGTGCCGCTGTTCACGGTCGACGCGGACGGCGACCGGCTCGTCCACGACCACCGCACGCCCGTCCCGGCGACGCTGGAGGCGGGCCCGCTGGAGCACGCGGCGGCGCGCATCCGGGGGCTGACCACGCGCAACCGCGTCCAGCAGGACCAGTACATCGCGGCGGGCCTGGCGGGCGGCGACGTCACCAGCGCGGACTTCGCGGCGACGTGCGTGGAGCAGGCGGCGGCGCTCGGCGAGCGGCTGTGCGCGGCGCTGCGCCCGCAGGACGCGCCCGCGCCGTGGACGTCGTACGTCATCACCGCCGAGGGCCGCACCGAGGTGGACATCGAGGGCGACCTCTACAACGGGTCGGCGGGCATCGCGCTGTTCCTGGCGTACCTGAACGACCTCGACCCGCGCCCGGAGTTCGAGCACGCGGCGCGACGGGCGCTCGACCACGCGCTGGCGTCCCTGGACGGCGAACGCATCGGCGCGTTTCCCGGCACGGGCGGGCTGATCTACACGCTGCTGCACCTGCACGCGCTGTGGGGCGAGTCCGCGCTGCTGGACCGCGCGGTCGCCCTGGCCGACCGGATCGACGGGCTCATCGAGCAAGACCGGCATCTGGACGTCTTCCACGGCGTCGCCGGACTCGTCCCGGTGCTGCTGGCGCTGGCCGACGCGACCGGCGGCCGGGGCGCCCGGCAGGCCCACCGGTGCGCCGCGCGCCTGCTCGCGACCGCGCGCGCCGACGGCGACGTCCTGTCCTGGCCGAACAGCGACCCGGCGGCCTCCCTCGCGGACCTGACCGGCCTGTCGCACGGCAGCGGCGGGATCGGCTGGGCGCTGACCCTGCTCGGGACGCGCGCCGACCGGCCCGAGTACCTGTCGGCGGCGCGGCGCGCGTTCGCCTACGAGGCCCGGCACTTCGACGCCGACGCGCAGGACTGGTACGACCTGCGGACCGTCGCGGGCGGCCCGACGCGCGGCGGCCGCCACTACGCCAACGCGTGGTGCAACGGCGCGTCCGGGATCGGGCTGACGCGGATCGCGAGCTGGTCGCTGCTCGGCGGCGACGACGAGGAGCTGCTGCGCGACGCGACCGTCGCGCTGACCACGACGATGCGCAACTTCCCCCGGCTCGGCAACGACTCGCTGTGCCACGGCCGGACGGGCAACGCCGAGCTGTTCCTGCGCTACGCGCTGCTGCGCGACCAGCCCGCGTTCCGGCTGGAGGCCAACGTGCAGGCGCAGTCCCAGTGGCGCGACCTGGGCGGCGCGCGGCCGGGCCGGGAGGCGGGCTTCTTCCCCGGCCTGATGCTCGGGCTCGCCGGGTTCGGCACGCACTTCCTGCGGCTGGCGCGGCCGGACCGGGTGCCCTCGGTGCTGCTGCTGGACCCGCCGCGGGCGTCCACCAACTGA	MNQLYPADIAARAANLSERARIVAALAPPPDAPHPGAGPLDPFDAWKTRRVADRLAARFREEARRGAAPARHTEAALTETLTAYRRHELGLADPADPFGRAVRDAQRAWLPVYTAALDGFRPESEEAARAGWREPEVYYGRLAKACEPFLLELGRRLTAVLDAAPGAGPVVDRRLVEEFQLRLLDRFALALAWAVEADTKVYCRLRGIDPATATTDDYLAFLDKTFADAESYHRFYLDFPVLGRWLAHTTGLLAEHGRDLVVRLRRDAADVGAAFFGQPVAAVRSAGLGRSDDHAGARGVVMVGAELADGTEATFVYKPRCVRGEAGLQRLLVRLRADGVLDFADRAVLPRDGYGYEALIPAGRNRVATREAARPVYAELGGYLAIFYVLGGGDLHFENVLVADGHAFVCDCETVLGALPKGQPRPAGTLMDSVFKTGLIEWPTPPDAAGEMRLSGYSGGGSFELPMPVPQLGDRRMSFEASVTHRAGLRVDPGSANRVFVGDGLAAPEEYVADVKDGFDRVYRWFQDDPDGTAAQVAELFSGTRVRFVNWSTQIYTQLLLAARHPKCLMDPLEVDLLFNTVRTFPRNWDVEGVLPAWELESMWRLDVPLFTVDADGDRLVHDHRTPVPATLEAGPLEHAAARIRGLTTRNRVQQDQYIAAGLAGGDVTSADFAATCVEQAAALGERLCAALRPQDAPAPWTSYVITAEGRTEVDIEGDLYNGSAGIALFLAYLNDLDPRPEFEHAARRALDHALASLDGERIGAFPGTGGLIYTLLHLHALWGESALLDRAVALADRIDGLIEQDRHLDVFHGVAGLVPVLLALADATGGRGARQAHRCAARLLATARADGDVLSWPNSDPAASLADLTGLSHGSGGIGWALTLLGTRADRPEYLSAARRAFAYEARHFDADAQDWYDLRTVAGGPTRGGRHYANAWCNGASGIGLTRIASWSLLGGDDEELLRDATVALTTTMRNFPRLGNDSLCHGRTGNAELFLRYALLRDQPAFRLEANVQAQSQWRDLGGARPGREAGFFPGLMLGLAGFGTHFLRLARPDRVPSVLLLDPPRASTN	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	174.47	gnl|BL_ORD_ID|1112|hsp_num:0	1210			315	522	novobiocin
BGC0001364.1|Cinnamycin_16 # 15476 # 16489 # -1 # ID=1_16;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.757	BGC0001364.1|Cinnamycin_16 	15476	16489	-	Loose	700	25.409	vanS gene in vanB cluster	25.0	3002932	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	CGGATGGCGGGCAGGGGCACGCGCCCGACGCTGGAGGAGGTCGCGGCGCGGGCCGGCGTCGGCCGCGGGACGGTGTCGCGGGTCGTCAACGGCTCGCCGCGGGTCAGCGAGCAGGCCCGCGCGGCGGTGCTCAAGGCGATCGAGGAACTGGGCTACGTGCCGAACCGGGCGGCGCGGTCGCTGGTGACGCACCGGACCGACACGGTCGCGCTCGTCGTCGCCGAATCCGACCAGCGGCTGTTCGGCGAGCCCTACTTCGCCGGGATCATCCGGGGCATCAGCACCGCGCTCGGGGACACCGGGCTGCAACTGCTGCTCGCGCTCGCCCGCTCGCCCGGCGAGTACGCGCGGCTCGCGGACTACCTGACCGCGCAGCACGTCGACGGCGTCCTGCTGACGTCGCTGCACGCGGAGGACCCGCTGCCCGCCAAGCTGGAGGCGGGCGGCGTGCCGACCGTCCTCGGCGGGCGGCCGCCCGGCCTGTCGCCGGTCAGCTACGTGGACGTGGACAACCGCAGCGGGGCGCGGCAGGCCGTCGAGCACCTCGTCGCGCACGGCCGCCGCCGGATCGCCACGATCGCCGGGCCGCAGGACATGGGCGTCGGCATCGACCGGCTCGGCGGCTACCGCGACGCGCTCGCGGACGCGGGGCTGCCCGAGCTGATCGCCTACGGGGACTTCAGCGAGGCCAGCGGCATCGCGGCCGCGGAGGAACTCCTCGCGCGCGACCCGGGCCTCGACGCCGTTTTCGCCGCCGACGACCCGATGGCGCTCGGCGCGCTGCGCGTCCTGCGGCGGCTCGGGCGGACCGTCCCCGGCGACGTGGCCGTCGTGGGCTTCGACGACTCGGCCGCAGCGCCCCTCGCGGACCCGCCGCTGACGACCGTCCACCAGTCCCCCGAGGAGATGGGACGGGAGATGGCGCGGCTGCTCGTGGCGCGCATTCGCGGCGAGGACCTGGACGAACCGGTCGTGATACTGCGGCCGCATCTGGTGAAGCGGGAGTCGGCGTAG	RMAGRGTRPTLEEVAARAGVGRGTVSRVVNGSPRVSEQARAAVLKAIEELGYVPNRAARSLVTHRTDTVALVVAESDQRLFGEPYFAGIIRGISTALGDTGLQLLLALARSPGEYARLADYLTAQHVDGVLLTSLHAEDPLPAKLEAGGVPTVLGGRPPGLSPVSYVDVDNRSGARQAVEHLVAHGRRRIATIAGPQDMGVGIDRLGGYRDALADAGLPELIAYGDFSEASGIAAAEELLARDPGLDAVFAADDPMALGALRVLRRLGRTVPGDVAVVGFDDSAAAPLADPPLTTVHQSPEEMGREMARLLVARIRGEDLDEPVVILRPHLVKRESA	MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSDRLDMQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVAQSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKEVPPPLERKDELGALAHDMHSMYIRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIAAVSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKTISEILELVSLNDGRIVPIAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPKLIQKALSNVILNAVQNTPQGGEVRIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLDAMSLQYALENTSDGVLFWLDLPPTSTL	75.39	gnl|BL_ORD_ID|4672|hsp_num:0	499			795	924	vancomycin
